HDAC9 and neoplasm: Epigenetic strategies for reprograming CAR-Ts, including DNMTs inhibitors, HDAC inhibitors, ncRNAs, or multiplex modifications, have allowed CAR-Ts to persist long-term following adoptive transfer, mitigate exhaustion, enhance trafficking to the tumor, and boost their therapeutic effectiveness.